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ABSTRACT Acinetobacter baumannii is a nosocomial pathogen of increasing importance due to its multiple resistance to antibi-
otics and ability to survive in the hospital environment linked to its capacity to form biofilms. To fully characterize the contribu-
tion of AdeABC, AdeFGH, and AdeIJK resistance-nodulation-cell division (RND)-type efflux systems to acquired and intrinsic
resistance, we constructed, from an entirely sequenced susceptible A. baumannii strain, a set of isogenic mutants overexpressing
each system following introduction of a point mutation in their cognate regulator or a deletion for the pump by allelic replace-
ment. Pairwise comparison of every derivative with the parental strain indicated that AdeABC and AdeFGH are tightly regulated
and contribute to acquisition of antibiotic resistance when overproduced. AdeABC had a broad substrate range, including
-lactams, fluoroquinolones, tetracyclines-tigecycline, macrolides-lincosamides, and chloramphenicol, and conferred clinical
resistance to aminoglycosides. Importantly, when combined with enzymatic resistance to carbapenems and aminoglycosides,
this pump contributed in a synergistic fashion to the level of resistance of the host. In contrast, AdeIJK was expressed constitu-
tively and was responsible for intrinsic resistance to the samemajor drug classes as AdeABC as well as antifolates and fusidic
acid. Surprisingly, overproduction of AdeABC and AdeIJK altered bacterial membrane composition, resulting in decreased bio-
film formation but not motility. Natural transformation and plasmid transfer were diminished in recipients overproducing
AdeABC. It thus appears that alteration in the expression of efflux systems leads to multiple changes in the relationship between
the host and its environment, in addition to antibiotic resistance.
IMPORTANCE Increased expression of chromosomal genes for RND-type efflux systems plays a major role in bacterial multidrug
resistance. Acinetobacter baumannii has recently emerged as an important human pathogen responsible for epidemics of
hospital-acquired infections. Besides its remarkable ability to horizontally acquire resistance determinants, it has a broad intrin-
sic resistance due to lowmembrane permeability, endogenous resistance genes, and antibiotic efflux. The study of isogenic mu-
tants from a susceptible A. baumannii clinical isolate overproducing or deleted for each of the three major RND-type pumps
demonstrated their major contribution to intrinsic resistance and to the synergism between overproduction of an efflux system
and acquisition of a resistance gene. We have also shown that modulation of expression of the structural genes for the efflux sys-
tems results in numerous alterations in membrane-associated cellular functions, in particular, in a decrease in biofilm formation
and resistance gene acquisition.
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Acinetobacter baumannii has emerged as a clinically and epide-miologically important nosocomial pathogen, essentially be-
cause of its ability to persist in the hospital environment and its
propensity to rapidly acquire antibiotic resistance mechanisms
(1). Multidrug-resistant A. baumannii strains are frequently
found to be responsible for epidemics of nosocomial infections,
such as respiratory, bloodstream, urinary tract, skin, and soft tis-
sue infections (1). In addition to its high capacity to acquire new
genetic determinants, overproduction of resistance-nodulation-
cell division (RND) efflux pumps with broad substrate specificity
has been shown to be associatedwithmultidrug resistance (MDR)
in A. baumannii (2). RND efflux systems, composed of an inner
membrane protein (RND pump) linked by a periplasmic adaptor
protein (PAP) to an outermembrane factor (OMF), can extrude a
wide range of substrates often unrelated in structure (3). To date,
three Acinetobacter drug efflux (Ade) RND systems, AdeABC (4),
AdeFGH (5), and AdeIJK (6), have been characterized in A. bau-
mannii. Overexpression of the AdeABC pump, primarily, and of
AdeFGH plays a major role in acquired resistance (2, 7), whereas
AdeIJK contributes to intrinsic resistance (6). Expression of each
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pump is tightly regulated by a different mechanism: AdeABC by a
two-component regulatory system, AdeRS (8), AdeFGH by the
LysR-type transcriptional regulator AdeL (5), and AdeIJK by the
TetR transcriptional regulator AdeN (9). The study of the relative
contributions of these threemost prevalent pumps in 14 clinical iso-
lates outlined the high incidence of adeABC overexpression inMDR
strains, resulting fromavarietyofpointmutations inAdeRS,whereas
only half of the strains had a slight increase in adeFGH expression
and, curiously, none overexpressed adeIJK (7).
Involvement of these pumps in antibiotic efflux was demon-
strated by the study of in vitromutants of clinical isolates overpro-
ducing the pumps and of deletionmutants obtained by insertional
inactivation of the structural genes for the pumps (4–6) and by the
use of efflux inhibitors. Interpretation of data obtainedwith efflux
inhibitors is difficult due to their lack of specificity, their own
antibacterial activity, and the multiplicity of the pumps (10).
Moreover, these studies provide limited, and sometimes discrep-
ant, findings on the respective roles of the pumps because of lack
of characterization of the parental strains, which are most often
MDR clinical isolates expressing complex sets of resistant deter-
minants (11).
In an attempt to better characterize the contribution of the
RND efflux systems to intrinsic or acquired resistance of A. bau-
mannii, we constructed from the susceptible and entirely se-
quenced clinical BM4587 isolate a set of isogenicmutants (i) over-
producing each of the three RND efflux systems as a result of a
single mutation in their cognate regulator or (ii) deleted in each
efflux system following clean allelic replacement. Pairwise com-
parison of every point mutant or of its deleted counterpart with
the parental strain led to precise characterization of the contribu-
tion of AdeABC and AdeFGH and of the contribution of AdeIJK
to acquired and intrinsic antibiotic resistance, respectively. In ad-
dition, this report documents the consequences of the level of
production of the pumps for biofilm formation, host motility,
competence, and conjugation, i.e., with respect to persistence of
this bacterial species and horizontal acquisition of resistance
genes.
RESULTS
Genomic features of A. baumannii BM4587. Clinical strain
BM4587, isolated in 2009 in France, was previously screened for
resistance determinants with a microarray and shown to be sus-
ceptible to antibiotics (12). Its genome is composed of a
3,913,120-bp circular chromosomewith a 39.0%GC content sim-
ilar to that of other sequenced A. baumannii isolates and of an
8,057-bp cryptic plasmid, pIP870. A total of 3,766 genes were an-
notated on the chromosome, including six rRNA clusters, 72
tRNAs, 3,665 predicted protein coding sequences (CDSs), and the
three RND efflux operons, adeABC, adeFGH, and adeIJK (see Ta-
ble S1 in the supplemental material). The AdeRS two-component
regulatory system of AdeABC and the AdeL LysR-type transcrip-
tional regulator of AdeFGH were transcribed in the opposite di-
rection upstream from the corresponding operon, whereas the
TetR-type transcriptional regulator AdeN was ca. 800 kb away
from the AdeIJK operon (Fig. 1). A. baumannii BM4587 encodes
seven RND efflux systems, but only AdeABC, AdeFGH, and
AdeIJK have been functionally defined. The remaining four
pumps are still putative.
In the phylogenetic tree obtained from a set of 133 core ge-
nomes of species of the genus Acinetobacter (13), BM4587 was
positioned in the clade of the 34 A. baumannii spp. (average nu-
cleotide identity, 97.7%). It was close to AB0057 (14), AYE (15),
andAB307-0294 (14), which belong to international Clonal Com-
plex 1 (CC1) (13). By MultiLocus Sequence Typing (Pasteur
scheme), the allelic profile of BM4587, 1-63-2-2-9-4-3, was shown
to correspond to new Strain Type 621.
A. baumannii is known to have a plastic genome with numer-
ous horizontally acquired mobile genetic elements. In contrast to
published chromosome sequences, including our own study re-
sults (13), no pathogenicity or resistance islands, insertion se-
quences (IS), transposons, or integrons were found in BM4587.
We detected only a truncated gene for a transposase (76% amino
acid [aa] identity for 50% profile coverage with transposase
ISRme19) which was not associated with an IS and two 51-kb and
41-kb putative prophages related to the rare podoviral bacterio-
phage YMC/09/02/B1251 ABA BP (16).
Construction of isogenic mutants overproducing or deleted
for Ade efflux pumps.We generated in vitro from BM4587 spon-
taneous resistant mutants overproducing the three main RND
efflux pumps on gradient agar plates containing gentamicin for
adeABC and chloramphenicol for adeFGH, as previously de-
scribed (17); the mutant overexpressing adeIJKwas obtained pre-
viously on a cefotaxime gradient (12) (see Table S2 in the supple-
mental material).
The derivatives differed from the parental strain by a single point
mutation in their respective regulators (see Table S2 in the supple-
mental material) which was confirmed by whole-genome sequenc-
ing. The two variants overexpressing adeABC, BM4688[madeABC]
AdeSR152K in the sensor and BM4689[madeABC] AdeRA91V in the
response regulator of the two-component regulatory system, had
already-reported mutations. The AdeSR152K substitution near phos-
phorylatable histidine 149 is a mutational hot spot in clinical iso-
lates overexpressing adeB (7), and AdeRA91V in the signal receiver
domain was obtained in vitro (18). Overexpression of the pump
was quantified by reverse transcription-quantitative PCR (RT-
qPCR). We were able to detect adeB expression in the parental
strain but at a very low level (0.01-fold less than that seen with
rpoB or secE genes). The adeG expression was similarly low, less
than 0.2-fold that seen with the rpoB and secE. These figures ex-
plain why there were no changes in the MIC values for both dele-
tion mutants from those for the parental strain. In contrast, the
adeJ gene was expressed at levels similar to (1.1-fold) those seen
with rpoB and secE, which was consistent with themembrane pro-
tein data (Table 1). BM4688[madeABC] presented expression
that was increased 60-fold for adeA, 38-fold for adeB, and 10-fold
for adeC compared to the levels seen with the parent, whereas
BM4689[madeABC] had expression levels of adeABC that were
nearly 5 times higher (Fig. 2).
Two adeFGH-overexpressing derivatives, BM4690[madeFGH]
with an AdeLQ332stop mutation and BM4691[madeFGH] with
AdeLN334H, were obtained. Mutations in the C-terminal region of
LysR-type regulators confer constitutive expression of the target
genes (5). In the two mutants, adeFGH was greatly (ca. 80 to 750
times) overexpressed compared with the BM4587 results (Fig. 2).
The BM4666[madeIJK] derivative has an adeNC584 mutation
(9) and presented expression that had increased 13-fold for adeI,
6-fold for adeJ, and 10-fold for adeK (Fig. 2). AdeN is a transcrip-
tional regulator belonging to the TetR family (9), and, as already
mentioned, the coding gene is located 802 kb distant from the
adeIJK operon (Fig. 1). To characterize potential global regulatory
Yoon et al.
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activity frequently associated with this type of transcriptional ac-
tivator, Biolog phenotypic microarray analysis was carried out for
BM4666[madeIJK] in comparison with BM4587. This arraymea-
sures bacterial respiration changes under different culture condi-
tions. The responses to the various antibiotics were consistent
with the decreased susceptibility of the mutant to the drugs (see
below and Table 2). Otherwise, no significant changes were found
under conditions of different carbon, nitrogen, phosphorus, sul-
fur, and peptide nitrogen sources and various osmolarity and pH
levels (data not shown). Strain BM4666[madeIJK] showed only a
slight stimulation of respiration in the presence of adenine, aden-
osine, or Tween 20. Of note, mutated AdeN resulted in moderate
overexpression of the pump, as already reported for other in vitro
mutants (9). Analysis of adeN loci in 34 A. baumannii genomes
(13) showed that high deduced aa conservation, with only three
strains in which AdeN was truncated, was associated with 4-fold,
3-fold, and 3-fold increased adeJ expression relative to BM4587
taken as a reference.
Clean-deletion mutants BM4717[adeB], BM4718[adeG],
and BM4719[adeJ], lacking an RND pump gene, were obtained
FIG 1 Graphical circular map of A. baumannii BM4587 chromosome. Circles display (from the outside) (1) genes for antibiotic resistance, motility, compe-
tence, biofilm formation, and a transposase in the clockwise direction; (2) predicted CDSs transcribed in the clockwise direction; (3) predicted CDSs transcribed
in the counterclockwise direction; (4) genes for antibiotic resistance, motility, competence, and biofilm formation in the counterclockwise direction; (5)
prophages; (6)Mol%GC deviation (mean GC content in a 1-kb window for overall mean GC); and (7) positive (green) and negative (purple) GC skew.
CGView software (60) was utilized to construct the genome map. Genes indicated in red represent those encoding antibiotic resistance; blue, motility and
competence; green, biofilm formation; gray, mobile elements; and magenta, the replication origin.
Ade Efﬂux Pumps in A. baumannii
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by two-step allelic exchange (see Fig. S1 in the supplemental ma-
terial) (19), and expression of the genes for the PAP, RND, and
outer membrane protein (OMP) components was determined by
RT-qPCR (Fig. 2). As expected, there was no expression of the
deleted genes and the genes for the PAPs were expressed at levels
similar to those in the parental strain. In contrast, the genes for
OMPs were expressed at levels less than half of those of the paren-
tal strain in both the BM4717[adeB] and BM4719[adeJ] deriv-
atives.
In contrast to report by others (10), we did not observe any
alterations in the expression of the other Ade RND systems in the
overproducing or deleted mutants for a single pump (data not
shown).
A. baumannii BM4587 and isogenic mutants overproducing
or deleted for Ade efflux pumps allow identification of antibi-
otic substrates. Broad intrinsic resistance in A. baumannii is due
to low membrane permeability, the presence of chromosomally
encoded -lactamases, and basal expression of efflux systems.
MDR in this species results from horizontal gene transfer but also
from overexpression of the pumps (1, 2).
Genes responsible for intrinsic and acquired resistance to an-
tibiotics were searched for in the BM4587 genome (Fig. 1; see also
Table S3 in the supplemental material). The genes for the two
intrinsic -lactamases of A. baumannii, blaADC for an AmpC-type
cephalosporinase (99% identical to ADC-52) and blaOXA-104 for
an OXA-51-type -lactamase, were present. The craA gene for a
TABLE 1 Proteins differentially expressed in A. baumannii isogenic mutants BM4689[madeABC] and BM4666[madeIJK] relative to BM4587
Locationa Protein
BM4689[madeABC] vs BM4587 BM4666[madeIJK] vs BM4587
Peptb Scorec ANOVA (P) Foldd Peptb Scorec ANOVA (P) Foldd
RND efflux system
BM4587v1_20947 AdeA 22 1577 4.47e-11 65.3
BM4587v1_20948 AdeB 4 210 2.89e-09 40.4
BM4587v1_20949 AdeC 17 991 5.66e-11 29.5
BM4587v1_10691 AdeI 17 1524 1.27e-06 3.9
BM4587v1_10690 AdeJ 11 552 7.78e-04 3.8
BM4587v1_10689 AdeK 21 1786 3.56e-05 2.5
Cell motility/adhesion
BM4587v1_21011 FimA, fimbrial adhesin protein 4 177 8.91e-04 33.9
BM4587v1_20439 CsuA/B; putative secreted protein related
to type I pili
5 378 1.69e-04 2.5 5 754 1.19e-04 3.2
BM4587v1_20442 CsuC; putative type I pilus usher
pathway chaperone
8 373 3.48e-03 2.8 7 321 2.19e-05 6.7
BM4587v1_10582 Omp38, outer membrane protein A 5 190 1.83e-05 2.9
BM4587v1_21772 Outer membrane protein A family 3 125 2.29e-03 2.6
Metabolism/amino acid
transport/
biosynthesis
BM4587v1_20210 DABA-AT, diaminobutyrate-2-
oxoglutarate aminotransferase
6 210 2.43e-05 3.8 7 431 4.52e-04 2.7
BM4587v1_21371 Amino acid ABC transporter periplasmic
protein
3 103 1.42e-03 2.6
BM4587v1_20299 TrpC, indole-3-glycerol-phosphate
synthase
4 173 1.97e-06 6.4 4 174 3.32e-03 2.5
BM4587v1_20152 AspC, aspartate aminotransferase A 4 152 2.40e-05 5.7 4 246 1.36e-03 2.5
BM4587v1_10396 RES, type III restriction enzyme, res
subunit
3 95 1.87e-03 5.8
BM4587v1_22098 BetA, oxygen-dependent choline
dehydrogenase
3 162 1.96e-03 2.6 3 130 1.23e-03 3.4
BM4587v1_10056 PurC, phosphoribosylaminoimidazole-
succinocarboxamide synthase
5 352 2.13e-06 3.0
BM4587v1_22207 FabD, malonyl-CoAe-[acyl-carrier-
protein] transacylase
4 489 2.10e-03 8.8 4 173 4.59e-04 3.6
BM4587v1_22458 FumA, fumarate hydratase 3 160 1.47e-03 2.6
BM4587v1_20069 EtfA, electron transfer flavoprotein
alpha-subunit
3 682 9.14e-05 2.5
DNA recombination
BM4587v1_10194 Ssb, ubiquitous ssDNAf binding protein 4 158 6.86e-04 2.4
a Structural gene location in A. baumannii BM4587 chromosome.
b Number of peptides for identification and quantification.
c Confidence score for identification by Mascot software.
d Fold change between the isogenic mutant and the parental strain; only values above a 2-fold change are indicated; negative values indicate underproduction.
e CoA, coenzyme A.
f ssDNA, single-stranded DNA.
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chloramphenicol-specific major facilitator superfamily (MFS) ef-
flux systemwas also found (20). An acquired aadA1 gene for a strep-
tomycin 3=-O-adenylyltransferase accounted for high-level strepto-
mycin resistance of BM4587. In contrast, acquired gene tetA for an
MFS pump did not confer resistance, as was the case for 6 of 14
A. baumannii isolates in our previous study (13).
Based on the drugMIC changes with respect to the pumpmu-
tants (Table 2), ampicillin for AdeABC and ticarcillin and aztreo-
nam for AdeIJK were weakly extruded. All cephalosporins were
substrates for AdeIJK, and ceftazidime and cefepime were also
substrates for AdeABC. The three carbapenems were substrates
for AdeABC, but only meropenem was a substrate for AdeIJK. Of
note, against the adeJ variant, but not against the adeB and
adeG variants, the MICs of most -lactams were lower than
those against parental BM4587, indicating basal expression of
AdeIJK, responsible for intrinsic resistance to these drugs, in the
latter strain. These data confirm our earlier reports based on over-
expressing and single-deletion or double-deletion derivatives (4,
6, 9) and are in good agreement with those obtained by others (11,
21–23) except for meropenem-AdeIJK in a single study (11). That
discrepancy could have resulted from the study of an MDR strain
producing a carbapenemase (11) masking the moderate effect of
efflux on carbapenems. No overexpression of ampC or OXA-51
was detected in strain BM4666[madeIJK]. RT-qPCR experiments
were carried out to determine if the expression of intrinsic ampC
and blaOXA-51-like genes was altered by the upregulation of the var-
ious efflux systems. No overexpression of ampC or of blaOXA-51-like
was detected in the BM4666[madeIJK] and BM4690[madeFGH]
strains. There was a significant 2-fold-lower level of production of
both -lactamases in strain BM4689[madeABC]. Therefore, the
increase in the MICs of carbapenems against the adeABC-
overexpressing mutant was not the result of overexpression of the
structural genes for the enzymes but was due solely to efflux of the
drugs.
All aminoglycosides were substrates for AdeABC. Importantly,
overexpression of the pump resulted in strain BM4689[madeABC]
being categorized as clinically resistant to gentamicin, netilmicin, and
tobramycin (24, 25).
Strain BM4587 was susceptible to nalidixic acid, norfloxacin,
and ciprofloxacin; these quinolones were substrates for the three
RND pumps.
Tetracycline and tigecycline were substrates for the AdeABC and
AdeIJKpumps andminocycline forAdeIJKonly. Thiswas not found
in another study forminocycline-AdeABC and tetracycline-AdeIJK
(22) and could have been due to the fact that the experiments were
carried out in different bacterial hosts, A. baumannii and Esche-
richia coli, which differ drastically in their outer membrane per-
meability (26).
Althoughmacrolides and lincosamides are thought to be inac-
tive against Gram-negative bacteria because of impermeability as-
sociated with the outermembrane (27), erythromycin and clinda-
mycinwere good substrates for AdeABC andAdeIJK. TheMICs of
both drugs against strain BM4719[adeJ] were largely decreased,
indicating that efflux contributes significantly to intrinsic resis-
tance to these two classes of drugs in A. baumannii.
Chloramphenicol was a substrate for the three RND pumps.
The MIC of the drug against parental BM4587 dropped from
64 g/ml to 16 g/ml for strain BM4719[adeJ], indicating that
efflux contributesmore to intrinsic resistance to chloramphenicol
than the MFS pump CraA.
Acinetobacter spp. are intrinsically resistant to low levels of tri-
methoprim and sulfonamides (27) due to AdeIJK activity; they
were also substrates for AdeFGH. The AdeIJK system was also
responsible for intrinsic resistance to fusidic acid and, to a much
lesser extent, to rifampin.
Colistin, which acts at the surface of the cells, was not a sub-
strate for any of the pumps.
The susceptibility of strainsBM4717[adeB]andBM4718[adeG]
was similar to that of parent strain BM4587, indicating that both
the AdeABC system and the AdeFGH system are tightly regulated
and are expressed only following induction by as-yet-unknown
signals ormutations in the cognate regulatory system (5, 8). There
was good correlation between the level of AdeABC expression and
that of resistance to the substrate drugs, since the MICs of sub-
strate antibiotics against strain BM4689[madeABC] were 1- to
4-fold higher than against strain BM4688[madeABC], which
overexpressed adeB at a level 4 times lower (data not shown).
Of note, deletion mutant BM4719[adeJ] had increased sus-
ceptibility to several antibiotic classes, -lactams, quinolones, tet-
racyclines, MLS, phenicols, antifolates, fusidic acid, and the bio-
cide triclosan (Table 2), consistentwith constitutive production of
FIG 2 Relative levels of expression of ade operons. Gene expression relative to
that of rpoB was determined by RT-qPCR. Results are presented relative to
parental BM4587 taken as a reference. Every isolate was tested in duplicate in
two independent experiments. The bars represent themeans and the error bars
the standard deviations. Genes indicated in white represent those encoding
periplasmic adaptor proteins; black, RND pumps; and gray, outer membrane
factors. **, P 0.01; *, P 0.05 (Student t test).
Ade Efﬂux Pumps in A. baumannii
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AdeIJK and with a major contribution of that pump to the broad
intrinsic resistance of A. baumannii.
E. coli-A. baumannii shuttle plasmid pCM88 confers resistance
to carbapenems by production of -lactamase OXA-23 and to
gentamicin by production of an AAC(3)-I (unpublished data).
This plasmid was electrotransformed into BM4587 and its
derivatives overexpressing the three efflux systems, and the MICs
of antibiotics for the transformants were determined (see Ta-
ble S4 in the supplementalmaterial). Therewas no consequence of
overexpression of the AdeFGH and AdeIJK pumps with respect to
the levels of resistance of the host strains (data not shown). In
contrast, theMICs of the carbapenems were 2-fold to 4-foldmore
elevated against strain BM4689[madeABC]/pCM88, and the gen-
tamicin MICs against that strain increased from 2,048 g/ml to
more than 4,096g/ml. Since AdeABC is the only system that can
extrude the carbapenems and the aminoglycosides, these data in-
TABLE 2 Antimicrobial susceptibility of A. baumannii BM4587 and derivatives
Antimicrobial agent
MICa (g/ml)
BM4587
BM4689
[madeABC]
BM4717
[adeB]
BM4690
[madeFGH]
BM4718
[adeG]
BM4666
[madeIJK]
BM4719
[adeJ]
-Lactams
Ampicillin 8 32 8 16 8 8 8
Ticarcillin 8 8 8 4 8 32 2
Aztreonam 32 16 32 16 32 128 4
Cephalothin 128 128 128 64 128 512 128
Cefuroxime 16 16 16 32 16 64 2
Ceftriaxone 4 4 4 2 2 16 4
Ceftazidime 4 16 4 4 4 8 1
Cefepime 1 16 1 0.5 1 4 0.5
Imipenem 0.125 0.5 0.125 0.125 0.125 0.125 0.125
Meropenem 0.5 2 0.5 0.5 0.5 2 0.125
Doripenem 0.25 4 0.25 0.25 0.25 0.5 0.125
Aminoglycosides
Streptomycin 32 1024 32 32 32 32 32
Neomycin B 2 16 2 2 2 2 2
Kanamycin 4 32 4 4 4 4 4
Tobramycin 2 16 2 2 2 2 2
Amikacin 2 16 2 2 2 2 2
Gentamicin 1 32 1 1 1 1 1
Netilmicin 1 128 1 1 1 1 1
Quinolones
Nalidixic acid 4 8 4 32 2 8 1
Norfloxacin 2 32 2 16 2 16 0.25
Ciprofloxacin 0.125 1 0.125 1 0.125 0.5 0.016
Polymyxin
Colistinb 0.5 0.5 0.5 0.5 0.5 0.5 0.5
Tetracyclines
Tetracycline 0.5 4 0.5 0.5 0.5 2 0.063
Minocycline 0.25 0.25 0.25 0.25 0.125 0.5 0.015
Tigecycline 0.125 2 0.125 0.25 0.125 0.5 0.031
Macrolide-lincosamide
Erythromycin 64 256 64 128 64 128 8
Clindamycin 512 2048 512 1024 512 1024 16
Phenicol
Chloramphenicol 64 256 64 512 64 256 16
Antifolates
Trimethoprim 16 32 16 64 16 128 2
Sulfadoxine 128 128 128 1024 128 256 8
Miscellaneous
Fusidic acid 128 128 256 128 256 512 8
Rifampin 1 1 1 1 1 2 0.5
Triclosan 4 4 4 8 4 8 1
a MICs were determined by microdilution according to the CLSI guidelines (54). Data in bold indicate values4 times the parental strain value.
b Microdilution MICs of colistin were determined according to the CLSI guidelines with the addition of Tween 80 at a final concentration of 0.002%.
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dicate an effect that is synergistic between efflux and other resis-
tance mechanisms.
Overexpression of adeABC and adeIJK alters bacterialmem-
brane composition. The proteomic analysis was performed on
cell envelope proteins and membrane or membrane-associated
proteins from both inner and outer membranes, obtained from
4-h bacterial cultures as previously described (28). Comparative
study of the envelope proteins ofA. baumanniiBM4587 and of the
mutants (Table 1) confirmed overproduction of the AdeA, AdeB,
and AdeC proteins (65-, 40-, and 29-fold changes, respectively) in
strain BM4689[madeABC] and of AdeI, AdeJ, and AdeK (3.9, 3.8,
and 2.5, respectively) in strain BM4666[madeIJK]. These data
were in good agreement with those given by RT-qPCR analysis
(Fig. 2). In the parental strain, only AdeA and AdeC proteins from
theAdeABC systemwere detected, whereas all three proteins from
the AdeIJK system were easily detected (data not shown). These
observations reinforce the notions that AdeABC is expressed at a
low level in the susceptible parent strain, its expression being un-
der stringent control (8), and that AdeIJK is constitutively ex-
pressed (6). Besides the overproduction of these Ade proteins, we
noticed underproduction of several interesting proteins in the
mutants (Table 1): (i) the CsuA/B and CsuC proteins underpro-
duced in both mutants are part of the CsuA/BABCDE type I pilus
system required for attachment to abiotic surfaces and for biofilm
formation (28, 29); (ii) in strain BM4666[madeIJK], a fimbrial
protein also involved in biofilm formation (30) was extremely
underproduced (34-fold); and (iii) in strain BM4689[madeABC],
production of the major OmpA protein, which plays a partial role
in biofilm formation on plastic and is essential for bacterial adher-
ence to A549 epithelial cells (31), was decreased nearly 3-fold.
Finally, both mutants underproduced the diaminobutyrate-2-
oxoglutarate aminotransferase (DABA-AT) involved in biosyn-
thesis of diaminopropane (DAP), a polyamine required for
A. baumannii surface-associated motility (32). Taken together,
these data suggest possible impairment in adhesion, biofilm for-
mation, and motility of the mutants overexpressing adeABC and
adeIJK.
Overexpression of Ade efflux pumps diminishes biofilm for-
mation but not motility. A. baumannii displays several forms of
motility on wet surfaces, including twitching motility at the agar-
petri dish interface, which is, in part, driven by type 4 pili (T4P)
(33), and the form of surface motility called “swarming”; both
types have been shown to depend on the synthesis of 1,3-
diaminopropane (32). There was no difference between parental
BM4587 and the mutants in the extent of motility. All the strains
moved with spreading zones of similar sizes at the agarose surface
and at the interface between agarose and the polystyrene of the
petri dish (see Fig. S2 in the supplemental material). Formation of
biofilms by A. baumannii BM4587 and the mutants on a solid
support and at the air-liquid interface was quantified by a crystal
violet colorimetric assay (Fig. 3). Consistent with the results of
proteomic analyses, overexpression of the efflux pumps resulted
in a decrease of biofilm and pellicle formation at 48 h. The
phenomenon was clearly highlighted by experiments per-
formed in 24-well plates (Fig. 3, white bars) that concomitantly
took into account the formation of pellicles and biofilms on the
walls of the well. If the impact on the BM4666[madeIJK] mu-
tant remained moderate, with a 36% decrease in biofilm forma-
tion, the impact on the other mutants was much more important,
with59%,63%, and82%decreases formutantsBM4688[madeABC],
BM4689[madeABC], and BM4690[madeFGH], respectively. Dele-
tion of the genes for the RND efflux pump in the BM4718[adeG]
and BM4719[adeJ] mutants restored the biofilm and pellicle
phenotypes of parent BM4587 (Fig. 3). The adeB mutant still
had a significant defect of 39% in biofilm formation, thus present-
ing behavior similar to that of E. coli and Salmonella enterica, in
which the deletion or inhibition of their efflux pumps was associ-
ated with decreased biofilm formation (34, 35).
Influence of overexpression of Ade efflux pumps on natural
transformation. The emergence of MDR A. baumannii relies, in
part, on acquisition of resistance determinants by horizontal gene
transfer. This can occur via conjugation, transduction, or trans-
formation. Since DNA uptake by transformation involves mem-
brane structures such as T4P and takes place during adhesion and
twitchingmobility (33, 36), increased expression of efflux systems
could alter cell competence. Motility and DNA uptake are associ-
ated with T4P and are abolished by inactivation of pilT, which
encodes theT4P retractionATPase, and ofComEC, aDNAuptake
channel. The genes for all key T4P components and competence
factors are present in the chromosome of strain BM4587 (Fig. 1;
see also Table S3 in the supplemental material).The transforma-
tion frequencies of the parental strain and of the mutant deriva-
tives during twitching motility were determined using genomic
DNA of A. baumannii mutant 179, which has a kanamycin resis-
tance gene cassette inserted in the sulfite reductase gene (36).
Strain BM4587 was naturally transformable at a very low rate, 3.0
 1010 ( 1.4 1010), and the transformation frequencies of
the pump mutants were similarly low. Under these conditions,
competence was detected in only 10 of 28 clinical isolates with
various transformation rates (from 1  104 to 6  108) and
only while twitching on semisolid medium was occurring (36).
Similarly, only three of nine fully sequenced A. baumannii strains
possessing all the competence genes (13) had transformation effi-
ciencies higher than 108. To study the influence of adeABC over-
expression on transformation, we performed selection on genta-
micin from the most transformable strain, A. baumannii clinical
NIPH 67 (13), an adeABC-overexpressingmutant. This derivative
had the same mutation, AdeSR152K, as the BM4688[madeABC]
mutant and displayed expression of adeB that was 31-fold in-
creased relative to that of NIPH 67. Its transformation frequency
FIG 3 Biofilm and pellicle formation by A. baumannii BM4587 and its de-
rivatives. Black bars, biofilms formed on Calgary device pegs; white bars, bio-
films and pellicles formed on 24-well plates. Percentages indicate 48-h biofilm
formation relative to parental BM4587 results taken as a reference. Experi-
ments were performed least three times independently, and results are pre-
sented as means SE. ***, P 0.0001; **, P 0.001; *, P 0.05. Numbers in
parentheses indicate fold increase in overexpression of the pump.
Ade Efﬂux Pumps in A. baumannii
March/April 2015 Volume 6 Issue 2 e00309-15 ® mbio.asm.org 7
 o
n
 O
ctober 29, 2019 at INSTITUT PASTEUR-Bibliotheque
http://m
bio.asm
.org/
D
ow
nloaded from
 
(6 109 3 109, P 0.05) was 4.1-fold lower than that of
parental strain NIPH 67 (2 108 9 109), suggesting that
overexpression of adeABC reduces DNA uptake by the host.
Plasmid transfer is diminishedbyoverexpressionofadeABC
and adeIJK in the recipient. In the genome of A. baumannii
BM4587, there were no type IV secretion systems which are in-
volved in conjugation and the pIP870 resident plasmid is cryptic
and not self-transferable. Conjugation was carried out using as a
donor A. baumannii NIPH 527 harboring the 6-kb mobilizable
pRAY plasmid conferring resistance to kanamycin (37) which is
widely distributed in A. baumannii (38). Since strain NIPH 527
has the MPFI conjugation machinery integrated in its chromo-
some (13), it can mobilize the Tra Mob pRAY plasmid. In
liquid medium, the frequency of transfer to strain BM4587 was
1.4  104 and was significantly (P  0.05) reduced to strain
BM4689[madeABC] (2.5 105) and strain BM4666[madeIJK]
(1.2 105) (Fig. 4, top panel). The frequency of transfer to strain
BM4717[adeB] was significantly increased (5.7  104, P 
0.01), but the frequency of transfer to strain BM4719[adeJ]
(2.0 104) remained unchanged. A. baumannii BM4587 and its
derivatives overexpressing or deleted for adeABCwere also used as
recipients in filter-mating experiments performed with A. bau-
manniiBM2580 harboring pIP1841, a plasmid self-transferable to
various Acinetobacter spp., such as A. baumannii, A. haemolyticus,
and A. lwoffii (39). The frequency of transfer of pIP1841 to
BM4587 was 1.5  107 ( 1.2  107) (Fig. 4, bottom panel).
The efficiency of conjugation to strain BM4689[madeABC] was
half that seen with the parent strain, whereas that to strain
BM4717[adeB] was 2.2-fold higher. Taken together, these data
indicate a decrease in conjugation efficiency for both plasmid
transfer types in the adeABC-overexpressing derivative.
DISCUSSION
The antibiotic substrate range of the three RNDefflux systemswas
determined by comparing the phenotype of strain BM4587 with
those of single-mutation derivatives overexpressing or deleted for
each pump (Table 2). The AdeABC mutants were representatives
of the clinical isolates, since they harbored the mutations in AdeR
and AdeS that are the most commonly found in clinical settings
and which conferred similar levels of overexpression of the pump
(7). To the best of our knowledge, no clinical strains with high-
level production of adeFGH have been reported, whereas adeIJK is
rarely overexpressed (7, 21; unpublished data on a collection of 25
entirely sequenced A. baumannii strains described in reference
13). The data indicate that AdeABC, which was found in 80% of
A. baumannii isolates, could extrude a wide range of antibiotics,
including the majority of -lactams and aminoglycosides, the
fluoroquinolones, tetracyclines-tigecycline, the macrolides-
lincosamides, and chloramphenicol. The mutant deleted for adeB
had MICs of all antibiotics indistinguishable from those against
parental BM4587, confirming that this pump is tightly regulated
by the AdeRS two-component system (8) and does not contribute
to intrinsic resistance of A. baumannii. Antibiotic efflux occurs
onlywhen the pump is overexpressed and, for certain drug classes,
such as aminoglycosides, can result in clinical resistance. In addi-
tion to the excellent correlation between the data obtained follow-
ing overexpression of the pumps and that obtained following de-
letion, which reinforces our conclusions on the substrate
specificities of this system, there was also a good relationship
between the level of expression of AdeABC and that of resis-
tance which could lead to differences in clinical categories for
doripenem and tobramycin of mutants overexpressing adeABC
at various levels (Fig. 2 and data not shown). This implies that
one should exert caution in assigning substrates to a pump
using a single overproducing variant.
Importantly, we observed that overexpression of adeABC,
which extrudes carbapenems and aminoglycosides, combined
with enzymatic resistance to these two classes of drugs,
contributes in a more than additive fashion to the level of resis-
tance of the host (see Table S4 in the supplemental material).
The AdeIJK system, which is present in all strains (6, 13), had
an extremely broad substrate specificity. The MICs of the antibi-
otics that were substrates for AdeIJKwere always lower against the
adeJ-deleted derivative than against parental BM4587. This indi-
cates that synthesis of AdeIJK is constitutive, as also demonstrated
by analysis of membrane proteins (Table 1), and that the pump is
responsible for intrinsic resistance of A. baumannii to all major
classes of antibiotics, including -lactams, fluoroquinolones, tet-
racyclines, MLS, phenicols, antifolates, and fusidic acid.
While proteomic analysis of bacterial membranes confirmed
the constitutive expression of AdeIJK, we highlighted, in mutants
overexpressing adeABC and adeIJK, the concomitant underex-
pression of proteins belonging to chaperone-usher (CU) pilus as-
sembly systems (Table 1): (i) the CsuA/B and CsuC proteins,
which are part of the CsuA/BABCDE type I pilus system, the ex-
pression of which is activated by the BfmRS transcriptional regu-
latory system (29, 40), and (ii) the FimA fimbrial protein. Pilus
FIG 4 Effect of overproduction or deletion of Ade efflux pumps on plasmid
transfer. Conjugation experiments were carried out in liquid (top) or on solid
(bottom) medium. Relative plasmid transfer frequency data represent the ra-
tio of transconjugants per donor to that of parental BM4587 used as a recipi-
ent. The data are the means and standard deviations of the results of at least
seven independent experiments. **, P 0.001; *, P 0.05.
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systems are known to have a major role in establishing the initial
stages of biofilm formation, promoting initial adhesion and sur-
face colonization but also formation of microcolonies (41). Both
pilins CsuA/B and FimA were detected in the matrix of different
A. baumannii pellicles (42), and the disruption of both CU sys-
tems results in a severe decrease in biofilm formation on abiotic
surfaces (29, 30). Furthermore, theOmpAmajor outermembrane
protein, also underexpressed in the BM4689[madeABC] mutant,
is an adhesin required for bacterial adherence to epithelial cells
and contributes to the process of biofilm formation (31). There-
fore, reduced production of these proteins correlatedwell with the
decrease in formation of biofilm and pellicle by the mutants over-
expressing the efflux pumps (Fig. 3). It may be noted that such a
negative correlation between overexpression of efflux systems
leading to antibiotic resistance and decreases in biofilm formation
has recently been observed in a transcriptomic analysis of
imipenem-selected A. baumannii (43). Conversely, a high
capacity of MDR clinical isolates of A. baumannii to form biofilm
and to adhere to respiratory epithelial cells has been previously
demonstrated (44). The contribution of Ade efflux systems to the
decrease in biofilm formation remains difficult to explain. But it
has been shown in P. aeruginosa that biofilm formation and anti-
biotic resistance could be controlled antagonistically via the Roc
two-component systems. The cupC genes for Cup fimbriae (as-
sembled by the chaperone-usher pathway) contributing to biofilm
formation would be upregulated by these regulators, whereas the
mexAB and OprM genes would be concomitantly downregulated
(41). The proteomic analysis also demonstrated a reduction of the
expression of DABA-AT, involved in biosynthesis of DAP in the
mutants overexpressing adeABC and adeIJK (Table 1). In Yersinia
pestis, the absence of polyamines reduces drastically the expres-
sion of the HmsR and HmsS hemin storage proteins that are in-
volved in poly-N-acetylglucosamine polysaccharide synthesis
and the expression of HmsT, a diguanylate cyclase responsible for
the synthesis of the secondary messenger c-di-GMP (cyclic
diguanosine-5=-monophosphate), a key regulator in biofilm for-
mation (45, 46). Thus, in mutants of Y. pestis and Vibrio cholerae
deficient in synthesis of putrescine and norspermidine poly-
amines, respectively, biofilm formation is severely impaired (47,
48). It appears that, similarly, reduced synthesis of DAP inA. bau-
mannii may contribute to the decrease in biofilm formation.
Deletion or inhibition of efflux pumps in E. coli and S. enterica
has been associated with a significant decrease of biofilm forma-
tion (34, 35, 49). However, inA. baumannii, biofilm formation by
the mutants lacking RND pump genes adeG and adeJ was very
similar to that of the parental strain. Only the adeBmutant pre-
sented a significant defect in biofilm formation (Fig. 3). In S. en-
terica, this defect was demonstrated to be related to repression of
curli biosynthesis (50), but A. baumannii BM4587 lacks the ho-
mologous cgs genes involved in the curli biosynthesis pathway. Of
note, exposure of P. aeruginosa to efflux inhibitors does not result
in a significant reduction of biofilm formation (34). The impact of
expression or inhibition of efflux systems on biofilm formation
may be dependent on the bacterial species.
In addition to efflux, emergence of MDR A. baumannii relies
on the ability to acquire antibiotic resistance genes by horizontal
transfer. A. baumannii possesses the complete set of genes re-
quired for transformation (13), but natural competence in asso-
ciation with T4P production and twitching motility in a clinical
isolate was found only recently (33). DNA uptake was further
demonstrated in 10 of 28 clinical isolates with various transforma-
tion rates (from 1 104 to 6 108) but only while the organ-
isms were moving on semisolid media (36). Strain BM4587 was
not transformable under similar conditions, although twitching
mobilitywasobserved.Ofnote, therewerenodifferences in two types
of motility, twitching and surface mobility, between parental
BM4587 and the mutants, although proteomic analysis of the
BM4689[madeABC] and BM4666[madeIJK] mutants demon-
strated underexpression of the DABA-AT involved in biosynthesis
of DAP a polyamine required forA. baumannii surface-associated
motility (32). The impact of the level of AdeABC pump produc-
tion on competencewas thus studiedwith another pair of isogenic
strains, and the results demonstrated a diminution of transforma-
tion in the overexpressingmutant.Ofnote, a 2.4-folddecrease of an
Ssb single-strandedDNAbinding protein was observed in themem-
brane of the BM4689[madeABC] mutant (Table 1). In Gram-
positive bacteria, protein SsbB is increasingly expressed during com-
petence for genetic transformation (51).
These observations indicate that the inducing conditions for
competence in A. baumannii are still poorly understood. Expo-
sure of some bacterial species to certain antibiotics, in particular,
bactericidal drugs, induces competence (52). Overexpression of
efflux pumps, as a result of increases in theMICs of a large number
of antibiotics, allow cells to survive in the presence of the drugs,
providing themwith a longer period of time to become competent
and, ultimately, MDR by acquisition of foreign resistance genes.
The influence of antibiotics on A. baumannii natural transforma-
tion remains to be studied. The biological cost of overproduction
of the various efflux systems and the putative consequences with
respect to the virulence of the host are currently under study.
In two types of plasmid transfer, mobilization and conjuga-
tion, overexpression of adeABC and adeIJK by the recipient re-
sulted in reproducible reduction of transfer frequencies (Fig. 4). It
thus appears that, if overexpression of pumps contributes toMDR
by efflux, it decreases acquisition of foreign DNA by both trans-
formation and conjugation. Alternatively, if acquisition of exoge-
nous resistance genes occurs first, then efflux contributes in a
synergistic manner, quantitatively and qualitatively, to resistance
of the host.
In conclusion, our report stresses that, to be truly informative
on the substrate ranges and the contribution of efflux systems to
acquired and intrinsic resistance to antibiotics, the work (i)
should be carried out on the bacterium of interest, rather than on
a surrogate species, because of the impact of variations in levels of
outer membrane permeability on the resistance phenotype, (ii)
should be carried out on isogenic single-mutant derivatives over-
expressing and deleted for each pump derived from a susceptible
strain and (iii) should be carried out on those harboring various
mutations reflecting the genetic events most commonly found in
clinical isolates because of the important contribution of the levels
of expression of the structural genes for the various systems, and
(iv) should address the putative synergism between the pumps
and the other mechanisms of resistance to a given substrate.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions.The bacterial strains
and plasmids used in this study are described in Table S2 in the supple-
mental material. Bacteria were grown using brain heart infusion (BHI) or
Luria-Bertani (LB) broth or agar at 37°C. Antibiotic susceptibility was
determined by disk diffusion onMueller-Hinton (MH) agar (53), and the
Ade Efﬂux Pumps in A. baumannii
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MICs were determined by microdilution in cation-adjusted MH broth
according to the CLSI guideline (54).
Selection of mutants overproducing RND efflux pumps. Spontane-
ous mutants were obtained from susceptible clinical isolate A. baumannii
BM4587 (12) on BHI gradient plates (17) containing 0 to 64 g/ml of
gentamicin for adeABC and 0 to 1,000 g/ml chloramphenicol for
adeFGH. Colonies growing at concentrations higher than the MIC were
tested for antibiotic resistance by disk diffusion, and those resistant to
several drug classes were selected for RT-qPCR analysis to quantify the
expression level of each RND pump.
Whole-genome sequencing.Bacterial whole-genome sequencing was
performed with Solexa single-read sequencing technology using a HiSeq
2000 system (Illumina) as previously described (9).
OGM of A. baumannii BM4587. A whole-genome restriction map of
BM4587 was produced through optical genome mapping (OGM) tech-
nology (55) using a MapCard kit and an enzyme kit-NcoI on an Argus
system (OpGen Inc.). The map was aligned with the in silico restriction
map predicted from contigs, allowing amplification of PCR products to
cover the gaps in the sequence (see Fig. S3 in the supplemental material).
During gap coverage, we found a ca. 21-kbCDS between positions 774542
and 795637. Bymegablasting the 3,249-bp 5= end and the 5,736-bp 3= end,
a biofilm-associated protein-encoding gene with repeated motifs, bap
(56), was found, and its size was estimated to be 21,095 bp by OGM.
Annotation and comparative genome analysis. CDSs were first pre-
dicted using AMIGene (Annotation of Microbial Genomes) software
(57). Each CDS was then submitted to automatic functional annotation,
and, as a final step, manual validation of automatic annotations was per-
formed using the Mage web interface as previously described (15).
DNAmanipulations and recombinantDNAtechniques.A. bauman-
nii genomic DNA was extracted using a Wizard genomic DNA purifica-
tion kit (Promega). DNA amplification was performed in a GeneAmp
9700 PCR system (PerkinElmer Cetus) with Phusion High-Fidelity DNA
polymerase (Thermo Scientific), and the PCR products were cloned in
pCR-Blunt vector with E. coli NEB5 as the host strain. Nucleotide se-
quencing was carried out with a ceq 8000 DNA analysis system automatic
sequencer (Beckman Instruments).
ConstructionofA. baumanniideleted foradeB,adeG, andadeJ.The
adeB, adeG, or adeJ gene was deleted by overlapping PCR and recombi-
nation according to the sacB-base strategy (see Fig. S1 in the supplemental
material) (19). Approximately 0.5-kb fragments upstream and down-
stream from the target genes were amplified from A. baumannii BM4587
genomic DNAusing primer pairs adeB1/adeB2 and adeB3/adeB4, adeG1/
adeG2 and adeG3/adeG4, or adeJ1/adeJ2 and adeJ3/adeJ4 (see Ta-
ble S5 and Fig. S1 in the supplemental material), linked by overlapping
PCR with primer pairs adeB1/adeB4, adeG1/adeG4, or adeJ1/adeJ4,
generating ca. 1-kb fragments that were cloned in pCR-Blunt with selec-
tion on kanamycin (50 g/ml). After sequencing of the inserts, the plas-
mids were digested by BamHI and NsiI (adeB and adeG) or BamHI
and PstI (adeJ) and the resulting fragments were ligated to BamHI/NsiI-
linearized pKNG101, generating pAT744, pAT745, and pAT746, respec-
tively, whichwere introduced intoE. coliDH5pir (58)with selection on
streptomycin (50 g/ml). The recombinant plasmids were transferred to
A. baumannii BM4587 by triparental mating. E. coliDH5pir harboring
pAT744, pAT745, or pAT746, E. coliHB101/pRK2013 (see Table S2) (59),
and recipient A. baumannii BM4587 were grown separately overnight at
37°C in LB supplemented with streptomycin for selection of the donors
and kanamycin for the helper plasmid. Aliquots of 0.5ml of the donor and
helper strains were centrifuged, and the pellets were suspended to an
optical density at 600 nm (OD600) of 4 in LB. Equal volumes were mixed,
and 50-l volumeswere spotted onMHagar in duplicate and incubated at
37°C for 2 h. Fifty microliters of the recipient strain was plated on the
spots, and conjugation was performed overnight at 37°C. Bacteria were
collected and resuspended in 1 ml of LB, and 50-l aliquots were spread
on LB agar plates containing streptomycin (300 g/ml) plus fosfomycin
(60g/ml) for counterselection of theE. coli strains and incubated at 28°C
for 3 days. Colonies were isolated, and single homologous recombination
events were screened for by PCR with primer pairs adeB7/adeB4 and
adeB1/adeB8 or primer pairs adeG7/adeG4 and adeG1/adeG8 or primer
pairs adeJ4/adeJ7 and adeJ1/adeJ8. Transconjugants were then plated on
LB agar containing 10% sucrose at 28°C for 24 to 48 h to induce expres-
sion of sacB and to select bacteria susceptible to sucrose. Deletion of the
target genes was confirmed by PCR with primer pairs adeB7/adeB8,
adeB7/adeB6, and adeB5/adeB8 or primer pairs adeG7/adeG8, adeG7/
adeG6, and adeG5/adeG8 or primer pairs adeJ7/adeJ8, adeJ7/adeJ6, and
adeJ5/adeJ8.
RNA isolation and RT-qPCR. A. baumannii total RNA was extracted
from exponentially grown bacteria (OD600, 0.8 to 0.9) using TRIzol re-
agent (Invitrogen). RNA samples were treated with Turbo DNA-free kit
(Applied Biosystems) to remove any genomicDNA carryover. Expression
of genes adeB, adeG, and adeJ was quantified by RT-qPCR as previously
described (12) using LightCycler RNA amplification kit SYBR green I
(Roche Diagnostic) with the following cycle profile: 1 cycle at 95°C for
30 s, followed by 45 cycles at 95°C for 5 s, 56°C for 10 s, and 72°C for 20 s.
The expression level of the rpoB gene ofA. baumanniiBM4587was used as
a reference (12). Each experiment was performed independently in dupli-
cate at least twice.
Proteomic analyses. Proteins from bacterial membranes of strains
BM4587, BM4689[madeABC], and BM4666[madeIJK] were extracted
from 4-h cultures as previously described (29). Briefly, after the bacterial
pellets were washed twice with sterile phosphate-buffered saline (PBS),
they were sonicated with a Branson Sonifier (Branson Ultrasonic) and
incubated 30 min at 37°C in lysosyme (0.7% [wt/vol])–50 mM Tris-HCl
(pH 7.4). Unbroken cells were eliminated by centrifugation at 10,000g
for 10 min at 4°C, and the supernatant was centrifuged at 100,000 g for
45min at 4°C. The (insoluble) pellet containing the cell envelope proteins
was resuspended in 20 mMTris-HCl (pH 7.4). Total protein content was
determined by the Bradford assay. Protein separation on polyacrylamide
gels, protein digestion by trypsin, and peptide extraction were performed
as previously described (29). Peptide extracts were separated by the use of
nano-liquid chromatography (nanoLC; Easy-nLC), and mass spectrom-
etry analyses were performed on an LTQ-Orbitrap Elite system (Thermo
Scientific) by injecting 1 l of sample. For each strain, three independent
extractions ofmembrane proteins were performed and two technical rep-
licates of each extract were analyzed. For protein quantification and iden-
tification, we used Progenesis LC-MS software (Nonlinear Dynamics),
retaining the same statistical parameters as previously described for pep-
tides (42). The merged peak list was searched against the A. baumannii
AYE database (http://www.ncbi.nlm.nih.gov/protein) using a local ver-
sion of Mascot (version 2.2; Matrix Science). Protein fold change was
taken into account when the value was above 2. At least 3 peptides were
used for protein identification and quantification.
Biofilm assays. Biofilm formation by A. baumannii BM4587 and its
derivatives was examined either on pegs using a Calgary device (Innovo-
tech, Edmonton, Canada) for solid-support biofilms (42) or in 24-well
plates for formation of biofilms together with pellicles (42). Biofilm bio-
mass was quantified after 48 h of growth at 37°C by crystal violet staining
as previously described (42). Assays were performed in triplicate at least,
and data are expressed as means  standard errors of the means (SE).
Results were analyzed using Prism Graph Pad 5 software by a one-way
analysis of variance (ANOVA) method to assess significant differences of
biofilm growth between the strains.
Motility and transformation. Motility and transformation experi-
ments were carried out as previously described (36). For both tests, plates
were composed of 0.5% agarose, 5 g/liter tryptone, and 2.5 g/liter NaCl.
The inoculumwas stabbed into the semisolidmedium to enable growth at
the surface and at the interface between the agar and the bottom of the
petri dish, and the plates were sealed with Parafilm to prevent drying. For
the interface growth (twitching), the medium was allowed to air-dry for
5 min before the stabbing. Formation of a biofilm at the interface was
visualized by crystal violet staining. For transformation, a suspension of a
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single colony in 20 l of PBS was mixed with an equal volume of trans-
forming DNA (400 to 800 ng/l of DNA from kanamycin-resistant
A. baumannii 179) (36) and stabbed into the motility plate (seven times,
with 2 l of the mixture used for each stabbing) and the Parafilm-sealed
plates were incubated for 18 h at 37°C. The bacteria were then flushed
from themotilitymediumwith 1ml of sterile PBS and plated on BHI agar
containing 30 g/ml of kanamycin. The number of CFU was determined
for calculation of transformation rates. Effective transformation was de-
termined on multiple colonies by PCR with 179-F and 179-R primers
(36).
Plasmid transfer. Spontaneous rifampin-resistant mutants from
A. baumannii BM4587 and derivatives were isolated on LB agar contain-
ing 100 g/ml of rifampin and used as recipients (see Table S2 in the
supplemental material). For the liquid method, A. baumannii NIPH 527
with conjugative-systemMPFI integrated in the chromosome andharbor-
ing kanamycin-resistant plasmid pRAY (38) was used as a donor. Equal
amounts of overnight cultures of the donor and of the recipient were
mixed, incubated in LB for 5 h, and diluted. Transconjugants were se-
lected by plating on LB agar containing rifampin (50 g/ml) and kana-
mycin (50 g/ml), purified, and tested by disk-agar diffusion. Plasmids
were extracted from randomly selected transconjugants and digested by
BamHI or HindIII, and the size of the resulting fragments was deter-
mined. For the standard filter method, A. baumannii BM2580 harboring
self-transferable plasmid pIP1841 (39) was used as a donor. Equal
amounts of donor and recipient overnight cultures in LB were harvested,
washed with an equal volume of LB, and mixed on a mating filter (Milli-
pore) placed on LB agar. After 5 h of mating at 37°C, cells were recovered
and plated on LB agar with antibiotics selective for donors (kanamycin at
50g/ml), recipients (rifampin at 50g/ml), and transconjugants (kana-
mycin at 50 g/ml and rifampin at 50 g/ml). The frequency was calcu-
lated as the number of transconjugants per donor.
Nucleotide sequence accession number. The assembled sequence of
A. baumannii BM4587 was submitted to the GenBank database and is
accessible under accession number JNOT00000000.
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